Retour
19
30
Fourchette du Jour
28,33 €
28,79 €
Fourchette 52 Semaines
24,24 €
36,80 €
Volume
1 213 990
Moyenne 50J / 200J
33,13 €
/
30,45 €
Clôture Précédente
28,41 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 21,8 | 0,2 |
| P/B | 3,4 | 3,0 |
| ROE % | 15,2 | 3,6 |
| Net Margin % | 3,7 | 3,8 |
| Rev Growth 5Y % | 13,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
38,14 €
+33.9%
Low: 35,00 €
High: 42,00 €
P/E Prévisionnel
15,25
BPA Prévisionnel
1,87 €
Croissance BPA (est.)
+0,0%
CA Est.
5,94B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,85 €
2,80 € – 2,90 €
|
8,33B | 1 |
| FY2029 |
2,58 €
2,54 € – 2,62 €
|
7,66B | 1 |
| FY2028 |
2,44 €
2,44 € – 2,45 €
|
7,03B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | 0,46 € | 0,46 € | 0,0% |
| 2025-10-30 | 0,43 € | 0,45 € | +4,7% |
| 2025-07-30 | 0,40 € | 0,41 € | +2,5% |
| 2025-04-29 | 0,36 € | 0,40 € | +11,1% |
| 2025-02-26 | 0,33 € | 0,35 € | +6,1% |
| 2024-10-30 | 0,31 € | 0,31 € | 0,0% |
| 2024-07-31 | 0,27 € | 0,30 € | +11,1% |
| 2024-04-23 | 0,23 € | 0,26 € | +13,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 13,22% annually over 5 years — strong growth
ROE of 15,20% — decent returns on equity
Debt/Equity of 0,00 — conservative balance sheet
Generating 258,45M in free cash flow
Cash machine — converts 124,50% of earnings into free cash flow
Capital efficient — spends only 0,00% of revenue on capex
Croissance
Revenue Growth (5Y)
13,22%
Revenue (1Y)13,03%
Earnings (1Y)-2,00%
FCF Growth (3Y)-11,43%
Qualité
Return on Equity
15,20%
ROIC19,11%
Net Margin3,67%
Op. Margin5,98%
Sécurité
Debt / Equity
0,00
Current Ratio1,53
Interest Coverage2,70
Valorisation
P/E Ratio
21,79
Forward P/E15,25
P/B Ratio3,41
EV/EBITDA12,69
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,03% | Revenue Growth (3Y) | 14,59% |
| Earnings Growth (1Y) | -2,00% | Earnings Growth (3Y) | -11,84% |
| Revenue Growth (5Y) | 13,22% | Earnings Growth (5Y) | 10,37% |
| Profitability | |||
| Revenue (TTM) | 5,65B | Net Income (TTM) | 207,59M |
| ROE | 15,20% | ROA | 6,01% |
| Gross Margin | 19,26% | Operating Margin | 5,98% |
| Net Margin | 3,67% | Free Cash Flow (TTM) | 258,45M |
| ROIC | 19,11% | FCF Growth (3Y) | -11,43% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 1,53 |
| Interest Coverage | 2,70 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 21,79 | Forward P/E | 15,25 |
| P/B Ratio | 3,41 | P/S Ratio | 0,80 |
| PEG Ratio | 5,98 | Forward PEG | N/A |
| EV/EBITDA | 12,69 | Fwd EV/EBITDA | 8,42 |
| Forward P/S | 0,76 | Fwd Earnings Yield | 6,56% |
| FCF Yield | 5,71% | ||
| Market Cap | 4,52B | Enterprise Value | 4,29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,65B | 5,00B | 4,30B | 3,94B | 3,44B |
| Net Income | 207,59M | 211,82M | 267,09M | 150,56M | 139,90M |
| EPS (Diluted) | 1,28 | 1,23 | 1,48 | 0,83 | 0,77 |
| Gross Profit | 1,09B | 1,01B | 981,22M | 866,92M | 779,61M |
| Operating Income | 337,91M | 321,83M | 314,60M | 240,23M | 190,84M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,46B | 3,42B | 3,33B | 3,23B | 2,93B |
| Total Liabilities | 2,13B | 2,02B | 1,91B | 1,85B | 1,75B |
| Shareholders' Equity | 1,33B | 1,40B | 1,42B | 1,39B | 1,18B |
| Total Debt | 0,0 | 1,22B | 1,17B | 1,16B | 1,16B |
| Cash & Equivalents | 232,62M | 412,57M | 343,85M | 294,19M | 119,42M |
| Current Assets | 1,26B | 1,32B | 1,09B | 994,34M | 710,26M |
| Current Liabilities | 829,35M | 780,15M | 618,31M | 565,35M | 459,70M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#994 of 1049
#369 of 619
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026